These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 857812)

  • 21. Myocardial infarction in young women with special reference to oral contraceptive practice.
    Mann JI; Vessey MP; Thorogood M; Doll SR
    Br Med J; 1975 May; 2(5965):241-5. PubMed ID: 1169093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
    Gossain VV; Sherma NK; Michelakis AM; Rovner DR
    Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral contraceptives and myocardial infarction.
    Thorneycroft IH
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1393-7. PubMed ID: 2220964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
    Nader S; Riad-Gabriel MG; Saad MF
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipids, cardiovascular disease, and oral contraceptives: a practical perspective.
    Upton GV
    Fertil Steril; 1990 Jan; 53(1):1-12. PubMed ID: 2403935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood glucose, insulin, cholesterol and triglyceride levels in women treated for six months with the weekly oral contraceptive R2323.
    Spellacy WN; Mahan CS; Buhi WC; Dumbaugh VA; Birk SA
    Contraception; 1978 Aug; 18(2):121-6. PubMed ID: 249676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of HLA types on carbohydrate effects of a low-estrogen oral contraceptive.
    Spellacy WN; Birk SA; Buhi WC
    Fertil Steril; 1980 May; 33(5):506-9. PubMed ID: 6989646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects.
    Olefsky J; Reaven GM; Farquhar JW
    J Clin Invest; 1974 Jan; 53(1):64-76. PubMed ID: 4357617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: the Telecom study.
    Simon D; Senan C; Garnier P; Saint-Paul M; Garat E; Thibult N; Papoz L
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):382-7. PubMed ID: 2196809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate and lipid studies during six months' treatment with megestrol acetate. Measurements of blood glucose, insulin, growth hormone, and triglycerides.
    Spellacy WN; Newton RE; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1973 Aug; 116(8):1074-8. PubMed ID: 4721135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbohydrate metabolism of Indian women taking steroid contraceptives.
    Barsivala VM; Virkar K; Kulkarni RD
    Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
    Horwitt MK; Harvey CC; Dahm CH
    Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the association between insulin and atherosclerosis.
    Stout RW
    Metabolism; 1985 Dec; 34(12 Suppl 1):7-12. PubMed ID: 3906363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contraception for the diabetic woman].
    Arlot S; Mesmacque A; Lalau JD; Quichaud J
    Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use.
    Spellacy WN; Ellingson AB; Tsibris JC
    Fertil Steril; 1989 Jan; 51(1):71-4. PubMed ID: 2642814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.